WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that the Company will present at the 11th Annual Needham Healthcare Conference. Tetraphase President and CEO Guy Macdonald will present for the company at 11:00 a.m. (ET) on Wednesday, April 4, 2012. The Conference will take place at The New York Palace Hotel in New York, New York.
